These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 25748474)
41. Changes in hepatic venous morphology with cirrhosis on MRI. Zhang Y; Zhang XM; Prowda JC; Zhang HL; Sant'anna Henry C; Shih G; Emond JC; Prince MR J Magn Reson Imaging; 2009 May; 29(5):1085-92. PubMed ID: 19388123 [TBL] [Abstract][Full Text] [Related]
42. Hepatocellular Carcinoma With Peliosis-Like Change-Mimicking Hemangioma: A LI-RADS Exception. Di Costanzo GG; Marino Marsilia G; Tortora R; Di Costanzo G; Ragozzino A Am J Gastroenterol; 2016 Jul; 111(7):1038-40. PubMed ID: 27356833 [No Abstract] [Full Text] [Related]
43. [Association of 2 autoimmune diseases with unusual clinical-laboratory manifestations and benign tumors of the liver]. Romanchishen AF; Kolosiuk VA Vestn Khir Im I I Grek; 2001; 160(1):98-100. PubMed ID: 11258337 [No Abstract] [Full Text] [Related]
44. CT and MRI of hepatic hemangioma. Jacoby JH; DiMarcangelo MT N J Med; 1991 Apr; 88(4):281-3. PubMed ID: 2038440 [TBL] [Abstract][Full Text] [Related]
45. Diffuse desmoplastic breast carcinoma metastases to the liver simulating cirrhosis at MR imaging: report of two cases. Nascimento AB; Mitchell DG; Rubin R; Weaver E Radiology; 2001 Oct; 221(1):117-21. PubMed ID: 11568328 [TBL] [Abstract][Full Text] [Related]
46. Conversion of a neonatal hepatic hemangioma to focal nodular hyperplasia. Turowski C; Feist H; Alzen G; Glüer S; Petersen C Pathol Int; 2009 Apr; 59(4):251-4. PubMed ID: 19351369 [TBL] [Abstract][Full Text] [Related]
47. Comparative diagnostic value of contrast-enhanced ultrasonography, computed tomography, and magnetic resonance imaging in diagnosis of hepatic hemangiomas. Zviniene K; Zaboriene I; Basevicius A; Jurkiene N; Barauskas G; Pundzius J Medicina (Kaunas); 2010; 46(5):329-35. PubMed ID: 20679748 [TBL] [Abstract][Full Text] [Related]
48. Comparison of portal venous and delayed phases of gadolinium-enhanced magnetic resonance imaging study of cirrhotic liver for the detection of contrast washout of hypervascular hepatocellular carcinoma. Cereser L; Furlan A; Bagatto D; Girometti R; Como G; Avellini C; Orsaria M; Zuiani C; Bazzocchi M J Comput Assist Tomogr; 2010; 34(5):706-11. PubMed ID: 20861773 [TBL] [Abstract][Full Text] [Related]
49. Contrast-enhanced ultrasound of histologically proven liver hemangiomas. Dietrich CF; Mertens JC; Braden B; Schuessler G; Ott M; Ignee A Hepatology; 2007 May; 45(5):1139-45. PubMed ID: 17464990 [TBL] [Abstract][Full Text] [Related]
50. Sparing of fatty infiltration around focal hepatic lesions in patients with hepatic steatosis: sonographic appearance with CT and MRI correlation. Kim KW; Kim MJ; Lee SS; Kim HJ; Shin YM; Kim PN; Lee MG AJR Am J Roentgenol; 2008 Apr; 190(4):1018-27. PubMed ID: 18356450 [TBL] [Abstract][Full Text] [Related]
51. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium. Gupta RT; Marin D; Boll DT; Husarik DB; Davis DE; Feuerlein S; Merkle EM Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122 [TBL] [Abstract][Full Text] [Related]
52. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient. Kim HJ; Kim BS; Kim MJ; Kim SH; de Campos RO; Hernandes M; Semelka RC J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959 [TBL] [Abstract][Full Text] [Related]